Jethwa, K. R., Tryggestad, E. J., Whitaker, T. J., Giffey, B. T., Kazemba, B. D., Neben-Wittich, M. A., . . . Hallemeier, C. L. (2018). Initial experience with intensity modulated proton therapy for intact, clinically localized pancreas cancer: Clinical implementation, dosimetric analysis, acute treatment-related adverse events, and patient-reported outcomes. Adv Radiat Oncol.
Citação norma ChicagoJethwa, Krishan R., Erik J. Tryggestad, Thomas J. Whitaker, Broc T. Giffey, Bret D. Kazemba, Michelle A. Neben-Wittich, Kenneth W. Merrell, Michael G. Haddock, and Christopher L. Hallemeier. "Initial Experience With Intensity Modulated Proton Therapy for Intact, Clinically Localized Pancreas Cancer: Clinical Implementation, Dosimetric Analysis, Acute Treatment-related Adverse Events, and Patient-reported Outcomes." Adv Radiat Oncol 2018.
Citação norma MLAJethwa, Krishan R., et al. "Initial Experience With Intensity Modulated Proton Therapy for Intact, Clinically Localized Pancreas Cancer: Clinical Implementation, Dosimetric Analysis, Acute Treatment-related Adverse Events, and Patient-reported Outcomes." Adv Radiat Oncol 2018.